HLA typing, blood transfusion, and cyclosporine in the North Italy Transplant Program

G. Sirchia, F. Mercuriali, M. Scalamogna

Research output: Contribution to journalArticle

Abstract

CyA had increased graft survival by 25% at one year in the NITP. The new drug, however, has not affected the importance of HLA matching and pretransplant antibodies in conditioning graft outcome. A limited number of pretransplant blood transfusions seems advisable in CyA-treated patients.

Original languageEnglish
Pages (from-to)86-89
Number of pages4
JournalTransplantation Proceedings
Volume17
Issue numberSUPPL. 2
Publication statusPublished - 1985

Fingerprint

Histocompatibility Testing
Graft Survival
Blood Transfusion
Italy
Cyclosporine
Transplants
Antibodies
Pharmaceutical Preparations
7-(4'-(2-nitroimidazole-1-yl)butyl)theophylline

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Sirchia, G., Mercuriali, F., & Scalamogna, M. (1985). HLA typing, blood transfusion, and cyclosporine in the North Italy Transplant Program. Transplantation Proceedings, 17(SUPPL. 2), 86-89.

HLA typing, blood transfusion, and cyclosporine in the North Italy Transplant Program. / Sirchia, G.; Mercuriali, F.; Scalamogna, M.

In: Transplantation Proceedings, Vol. 17, No. SUPPL. 2, 1985, p. 86-89.

Research output: Contribution to journalArticle

Sirchia, G, Mercuriali, F & Scalamogna, M 1985, 'HLA typing, blood transfusion, and cyclosporine in the North Italy Transplant Program', Transplantation Proceedings, vol. 17, no. SUPPL. 2, pp. 86-89.
Sirchia, G. ; Mercuriali, F. ; Scalamogna, M. / HLA typing, blood transfusion, and cyclosporine in the North Italy Transplant Program. In: Transplantation Proceedings. 1985 ; Vol. 17, No. SUPPL. 2. pp. 86-89.
@article{2bdf8e35f45b49e0afd63ad4937ae122,
title = "HLA typing, blood transfusion, and cyclosporine in the North Italy Transplant Program",
abstract = "CyA had increased graft survival by 25{\%} at one year in the NITP. The new drug, however, has not affected the importance of HLA matching and pretransplant antibodies in conditioning graft outcome. A limited number of pretransplant blood transfusions seems advisable in CyA-treated patients.",
author = "G. Sirchia and F. Mercuriali and M. Scalamogna",
year = "1985",
language = "English",
volume = "17",
pages = "86--89",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "SUPPL. 2",

}

TY - JOUR

T1 - HLA typing, blood transfusion, and cyclosporine in the North Italy Transplant Program

AU - Sirchia, G.

AU - Mercuriali, F.

AU - Scalamogna, M.

PY - 1985

Y1 - 1985

N2 - CyA had increased graft survival by 25% at one year in the NITP. The new drug, however, has not affected the importance of HLA matching and pretransplant antibodies in conditioning graft outcome. A limited number of pretransplant blood transfusions seems advisable in CyA-treated patients.

AB - CyA had increased graft survival by 25% at one year in the NITP. The new drug, however, has not affected the importance of HLA matching and pretransplant antibodies in conditioning graft outcome. A limited number of pretransplant blood transfusions seems advisable in CyA-treated patients.

UR - http://www.scopus.com/inward/record.url?scp=0022376303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022376303&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0022376303

VL - 17

SP - 86

EP - 89

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - SUPPL. 2

ER -